05-Feb-2018 | Zion Market Research
The new report by Zion Market Research on the “Biologics Outsourcing Market by Product (Antibody, Recombinant Protein, Vaccines, and Others), by Type (Kits & Reagents and Instruments), by Sources (Microbial, Mammalian and Others) and for Applications (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, and Stem Cell Research): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024" has a vast information about the market and its potential. The global biologics outsourcing market was valued at around USD 8,420.0 million in the year 2016 and it is expected to reach approximately USD 32,000.0 million by 2024. The global biologics outsourcing market is expected to exhibit a CAGR of more than 18.0% between 2017 and 2024.
Increasing investments in the research & development of biologics are significantly propelling the outsourcing market among the big as well as small pharmaceutical and biotechnological industries. Also, the robust supply chain ensured by the secondary manufacturer attract the companies for outsourcing of biologics which will ultimately boost the biologics outsourcing market during the forecast period
Browse the full "Biologics Outsourcing Market by Product (Antibody, Recombinant Protein, Vaccines, and Others), by Type (Kits & Reagents and Instruments), by Sources (Microbial, Mammalian and Others) and for Applications (Vaccine & Therapeutics Development, Blood & Blood-Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, and Stem Cell Research): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024" report at https://www.zionmarketresearch.com/report/biologics-outsourcing-market
Our research analysts observed that demand for the biologics outsourcing will increase significantly as the partnering enables pharma to focus on capabilities and minimize investment in specialized technologies and capacity while getting better products to patients faster.
The sector’s faster growth above the pharmaceutical industry is helped by the anticipated transition to more outsourcing, as well as the good growth within particular subsectors. Biologics contribute to the major segment by revenue in the pharmaceutical sector and are expected to continue during the forecast period. Biologics have received heavy investment for new facilities, motivated by anticipated growth and margins, whereas small molecules have been less favored. Overall, pharmaceutical outsourced manufacturing is expected to increase in the coming years.
There are several types of products in biologics which are outsourced. High use of antibodies for treating a number of chronic diseases such as asthma, diabetes the segment is expected to dominate biologics outsourcing market throughout the forecast period. The monoclonal antibodies sub-segment in antibodies will contribute to the major share owing to increased applications in the Pharma & biotechnology industries. The ongoing breadth and depth of research and innovation within the antibody engineering field ensures that monoclonal antibodies based products will boost the market.
Presence of a substantial number of products manufactured through the use of microbial sources is the major factor that is triggering the growth of the biologics outsourcing market. Thus, the microbial source is contributing a major share in the market growth.
The kits & reagents segment by type will hold the major share in the global biologics outsourcing market. Owing to their repeated use in clinical trials, and R&D activities.
The vaccine & therapeutics development are dominating the biologics outsourcing market in application segment due to the increasing disease prevention concern and increasing clinical infrastructure to develop more precise medications to meet the unmet need globally.
The market is growing at a rapid rate in the developed regions. North America dominates the biologics outsourcing market. Whereas Asia Pacific is having a significant share in the biologics outsourcing market and is anticipated to grow at highest CAGR. Owing to the huge research & developments that are made in some of the developing countries is flourishing the biologics outsourcing in Asia Pacific region
The major market players in the Biologics Outsourcing market are Boehringer Ingelheim GmbH, Catalent, Inc., GenScript, Innovent Biologics, Inc., Syngene, Shanghai Medicilon inc., GL Biochem Corporation Ltd., GVK Biosciences Private Limited, Horizon Discovery Group plc. Innovent Biologics, Inc., Selexis SA, Lonza, Abzena PLC, Adimab LLC., among others.
The global biologics outsourcing market is segmented on the basis of the product, type, sources, applications and the geographical regions.
Global Biologics Outsourcing Market: Product Segment Analysis
Global Biologics Outsourcing Market: Type Segment Analysis
Global Biologics Outsourcing Market: Sources Segment Analysis
Global Biologics Outsourcing Market: Application Segment Analysis
Global Biologics Outsourcing Market: Regional Segment Analysis
Browse New Press Release: https://www.zionmarketresearch.com/news/biologics-outsourcing-industry
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States.